WESPAC Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-222
| Closed | -$233K | – | 164 |
|
|
2024
Q2 | $233K | Sell |
222
-93
| -30% | -$97.7K | 0.18% | 135 |
|
|
2024
Q1 | $303K | Sell |
315
-4
| -1% | -$3.85K | 0.18% | 137 |
|
|
2023
Q4 | $280K | Sell |
319
-16
| -5% | -$14.1K | 0.19% | 122 |
|
|
2023
Q3 | $276K | Buy |
+335
| New | +$276K | 0.21% | 114 |
|
|
2023
Q2 | – | Sell |
-272
| Closed | -$223K | – | 129 |
|
|
2023
Q1 | $223K | Buy |
+272
| New | +$223K | 0.21% | 98 |
|
|
2020
Q3 | – | Sell |
-339
| Closed | -$211K | – | 107 |
|
|
2020
Q2 | $211K | Buy |
+339
| New | +$211K | 0.24% | 97 |
|
|
2016
Q1 | – | Sell |
-1,347
| Closed | -$731K | – | 121 |
|
|
2015
Q4 | $731K | Buy |
1,347
+516
| +62% | +$280K | 0.85% | 56 |
|
|
2015
Q3 | $387K | Sell |
831
-313
| -27% | -$146K | 0.68% | 45 |
|
|
2015
Q2 | $584K | Buy |
+1,144
| New | +$584K | 0.44% | 73 |
|